AzTrials
AzTrials

CommunicationNCT06624605

Enhancing Interdisciplinary Understanding of Ophthalmology Notes Through a Local Large Language Model

A study testing Large Language Model-generated Plain Language Summary of Ophthalmology notes in people with Communication and Artificial Intelligence (AI), run by John J Chen at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This prospective, randomized controlled trial evaluated the efficacy of adding Large Language model (LLM)-generated Plain Language Summaries (PLSs) to Standard Ophthalmology Notes (SONs) in enhancing comprehension among non-ophthalmology providers. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Large Language Model-generated Plain Language Summary of Ophthalmology notes
Could I receive a placebo?
No, everyone receives an active treatment
How many people
851 participants
Where
1 siteUnited States
Study dates
1 Feb 2024to 31 May 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Evaluation by an Ophthalmologist in the Mayo Clinic Department of Ophthalmology in Rochester, MN in either the inpatient or outpatient setting between Feb 1, 2024 - May 31, 2024.

Who cannot join

  • No in-network non-Ophthalmologist care providers in the medical record
  • Procedure-only visits containing only a procedure note

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Mayo Clinic

    Rochester, Minnesota, 55905

Other trials in United States

About this study

Official title: Enhancing Interdisciplinary Understanding of Ophthalmology Notes Through Local Large Language Model

This prospective, randomized controlled trial evaluated the efficacy of adding Large Language model (LLM)-generated Plain Language Summaries (PLSs) to Standard Ophthalmology Notes (SONs) in enhancing comprehension among non-ophthalmology providers. The study utilized surveys to assess non-ophthalmology providers\' comprehension and satisfaction with the notes and ophthalmologists\' evaluation of PLS accuracy, safety, and time burden. An objective semantic and linguistic analysis of the PLSs was also conducted.

Being tested
Large Language Model-generated Plain Language Summary of Ophthalmology notes
Medical subject headings
Communication

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Large Language Model-generated Plain Language Summary of Ophthalmology notesOther

    Prospective, randomized Quality Improvement study with real-world implementation of Large Language Model-generated Plain Language Summaries of Ophthalmology notes.

Study groups in NCT06624605
Study groupRoleWhat they receive
ControlNo interventionParticipants receive standard ophthalmology notes without any additions.
InterventionExperimentalParticipants receive standard ophthalmology notes with an appended LLM-generated plain language summary, reviewed and edited by the ophthalmologist. The plain language summary is clearly marked as generated as part of a Quality Improvement initiative.
Receives: Other: Large Language Model-generated Plain Language Summary of Ophthalmology notes

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Non-Ophthalmologist Note Comprehension and Satisfaction

    Assessed via survey responses evaluating understanding of the patient\'s ophthalmology diagnosis, satisfaction with the note, and overall preference between Standard Ophthalmology Note and Standard Ophthalmology Note + Plain Language Summary.

    Degree of understanding was assessed on the following Likert scale:

    Not at all Neutral Moderately A great deal

    Satisfaction was graded on the following Likert scale:

    Not satisfied at all Somewhat unsatisfied Neutral Somewhat satisfied Satisfied

    Preference between note types was assessed on the following Likert scale:

    Standard Note, a great deal Standard Note, somewhat Neutral Plain Language Summary, somewhat Plain Language Summary, a great deal

    Measured: From enrollment to 8 weeks after enrollment

Secondary outcomes (6)
  1. Ophthalmologist Evaluation of Summary Accuracy and Time burden

    Assessed via survey responses regarding Plain Language Summary accuracy in reflecting the Standard Ophthalmology Note findings, time spent reviewing/editing, and perceived burden.

    Accuracy in reflecting findings was graded on the following Likert scale:

    Not at all Neutral A little A great deal

    Time spent reviewing/editing was reported using the following options:

    \<1 minute

    1. minute
    2. minutes
    3. minutes
    4. minutes
    5. or more minutes

    Perceived burden was graded on the following Likert scale:

    Not at all Neutral A little A great deal

    Measured: Assessed at a single time point <24 hr after enrollment

  2. Semantic and Linguistic Quality of Plain Language Summaries

    Flesch Reading Ease

    Scale: 0 (poor) to 100 (good)

    Measured: Assessed at a single time point <24 hr following enrollment

  3. Semantic and Linguistic Quality of Plain Language Summaries

    Flesch-Kincaid Grade Level

    Scale: 0 (most difficult to read, highest grade level) to 80 (easiest to read, lowest grade level)

    Measured: Assessed at a single time point <24 hr following enrollment

  4. Semantic and Linguistic Quality of Plain Language Summaries

    Semantic Measure of Gobbledygook (SMOG) Index

    Scale: 0 (easiest to read) to 11 (most difficult to read)

    Measured: Assessed at a single time point <24 hr following enrollment

  5. Semantic and Linguistic Quality of Plain Language Summaries

    BERTScore Measure of Linguistic Similarity

    Scale: -1 (least similar) to +1 (most similar)

    Measured: Assessed at a single time point <24 hr following enrollment

  6. Semantic and Linguistic Quality of Plain Language Summaries

    SBERT Cosine Similarity Measure of Linguistic Similarity

    Scale: -1 (least similar) to +1 (most similar)

    Measured: Assessed at a single time point <24 hr following enrollment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Oct 2024
  2. Study start1 Feb 2024
  3. Primary completion31 May 2024
  4. Study completion31 May 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomized study assessing the efficacy of Large Language Model-generated Plain Language Summaries of Ophthalmology notes in increasing non-ophthalmologist note understanding. Notes were randomized to intervention (Summary + Original Note) or control (Original note only) arms. Non-ophthalmology providers were sent surveys assessing note comprehension for both control and treatment arm notes, and Ophthalmologists were sent surveys for intervention arm notes regarding Summary accuracy and other attributes. Conducted as a Quality Improvement initiative.
Masking
None (open label)
Enrolment
851 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06624605
Sponsor's protocol ID
24-000550
Status last verified
Oct 2024
First submitted
30 Sep 2024
Last updated
3 Oct 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: All collected IPD.

Questions about this trial

What is this clinical trial studying?

A study testing Large Language Model-generated Plain Language Summary of Ophthalmology notes in people with Communication and Artificial Intelligence (AI), run by John J Chen at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Non-Ophthalmologist Note Comprehension and Satisfaction (time frame: From enrollment to 8 weeks after enrollment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Oct 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in